# Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

> **NCT01774864** · PHASE3 · COMPLETED · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 349 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** DA-8159 (Udenafil)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01774864
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 349 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774864, "Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01774864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*